3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
2
Respiratory Aspiration
1
Pulmonary Atelectasis
1
Pneumothorax
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Diseases
1
Pericardial Effusion
1
Neoplasms
1
Neoplasm Recurrence, Local
1
Neoplasm Metastasis
1
Multiple Pulmonary Nodules
1
Mesothelioma, Malignant
1
Lung Diseases
1
Hemothorax
1
Empyema, Pleural
1
Airway Obstruction
1
Agnosia
1
Interventions
Carboplatin
18
Pemetrexed
10
Paclitaxel
6
pembrolizumab
5
Nivolumab
5
Cisplatin
5
Gemcitabine
4
osimertinib
3
entinostat
3
camrelizumab
3
atezolizumab
3
Erlotinib Hydrochloride
3
selpercatinib
2
pralsetinib
2
durvalumab
2
apatinib
2
Vinorelbine
2
Surveys and Questionnaires
2
One-Lung Ventilation
2
Ipilimumab
2
Drug Delivery Systems
2
Docetaxel
2
Bronchoscopy
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
zipalertinib
1
zimberelimab
1
toripalimab
1
taletrectinib
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Diseases
×
Anesthesia, General
×
Thoracic
×
Clear all
NCT05077111
2021-10-14
VATS
Ain Shams University
Phase 4
Unknown
40 enrolled